Epoch Biodesign, based in London, secured $18.3 million in a Series A funding round led by Extantia Capital. The company focuses on creating enzymes to improve recycling processes of plastics, making them as efficient as virgin materials. They have also received a $1 million UK government grant. Founded in 2019, Epoch has established over 40 partnerships across various sectors and employs a team of 30 scientists, aiming to tackle inefficiencies in traditional recycling through innovative enzyme technology and AI solutions.
Plastic has a bad reputation, but the problem isn't the material - it's how we use and dispose of it. When designed, sourced, and recycled responsibly, plastic can be one of the most efficient and sustainable materials we have.
They aren't just developing better recycling - they're transforming the entire value chain to ensure it works for the planet, not against it.
Collection
[
|
...
]